CDH1 and neoplasm: Huang et al argued that hsa_circ_000074, as a tumor promoter in CC, enhances the cellʹs ability to proliferate, migrate, and invade by reducing the expression of E‐cad and is a candidate target for the therapy of CC in the clinic.43